IGF2BP2 and neoplasm: Next, to clarify impacts of IGF2BP2 genetic polymorphisms on PCa clinicopathological characteristics, we analyzed factors such as pathologic staging, clinical staging, Gleason grade groups, tumor invasion, D'Amico classification, and BCR.